# EDGAR Filing Document

**Accession Number:** 0001098009
**File Stem:** 0001185185-23-000124
**Filing Date:** 2023-2
**Character Count:** 4858
**Document Hash:** 292ac30ef017c68f7c668ceaf8c4297d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001185185-23-000124.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001185185-23-000124

**CONFORMED SUBMISSION TYPE**: NT 10-Q

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**EFFECTIVENESS DATE**: 20230214

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** America Great Health
- **CENTRAL INDEX KEY:** 0001098009
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 980178621
- **STATE OF INCORPORATION:** CA
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** NT 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-27873
- **FILM NUMBER:** 23622754

**BUSINESS ADDRESS:**
- **STREET 1:** 1609 W VALLEY BLVD UNIT 338A
- **CITY:** ALHAMBRA
- **STATE:** CA
- **ZIP:** 91803
- **BUSINESS PHONE:** (888) 988-1333

**MAIL ADDRESS:**
- **STREET 1:** 1609 W VALLEY BLVD UNIT 338A
- **CITY:** ALHAMBRA
- **STATE:** CA
- **ZIP:** 91803

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CROWN MARKETING
- **DATE OF NAME CHANGE:** 20111006

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SPACE LAUNCHES FINANCING INC
- **DATE OF NAME CHANGE:** 19991028

------

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

------

**FORM 12b-25**

------

**NOTIFICATION OF LATE FILING**

☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR

For the Period Ended: **<u>December 31, 2022</u>**

☐ Transition Report on Form 10-K

☐ Transition Report on Form 20-F

☐ Transition Report on Form 11-K

☐ Transition Report on Form 10-Q

For the Transition Period Ended:

Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

------

**PART I - COMPANY INFORMATION**

---

| |
|:---|
| **America Great Health** |
| Full Name of Registrant |
| Former Name if Applicable |
| **1609 W. Valley Blvd., #338** |
| Address of Principal Executive Office (Street and Number) |
| **Alhambra, CA 91803** |
| City, State and Zip Code |

---

**PART II - RULES 12b-25 (b) and (c)**

If the subject report could not be filed without reasonable effort or expense and the Company seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)<br>

---

| | | |
|:---|:---|:---|
| ☒ | (a) | The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
| ☒ | (b) | The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and |
| ☐ | (c) | The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable |

---

**PART III - NARRATIVE**

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

The Company has not been able to compile the requisite financial data and other narrative information necessary to enable it to complete the Company's Quarterly Report on Form 10-Q by February 14, 2023 without unreasonable effort and expense.

------

**PART IV - OTHER INFORMATION**

(1) Name and telephone number of person to contact in regard to this notification:

---

| | | |
|:---|:---|:---|
| **<u>Mike Wang</u>** | **<u>(888)</u>** | **<u>988-1333</u>** |
| (Name) | (Area code) | (Telephone Number) |

---

(2) Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment Company act of 1940 during the preceding 12 months or for such shorter period that the Company was required to file such report(s) been filed? If the answer is no, identify report(s). ☒ Yes ☐ No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☐ Yes ☒ No

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

---

| | |
|:---|:---|
|  | **America Great Health** |
| Date: February 14, 2023 |  |
|  | By: /s/Mike Wang |
|  | Mike Wang |
|  | President/CEO |

---